Telomere Length in Precancerous Lesions of Ovarian Cancer Including p53 Signature and Incidental Serous Tubal Intraepithelial Carcinoma

被引：0
|
作者：
Asaka, Shiho [1 ]
Davis, Christine [2 ]
Lin, Shiou-Fu [3 ]
Wang, Tian-Li [2 ]
Heaphy, Christopher [1 ]
Shih, Ie-Ming [4 ]
机构：
[1] Johns Hopkins Univ, Sch Med, Baltimore, MD USA
[2] Johns Hopkins Med Inst, Baltimore, MD 21205 USA
[3] Taipei Med Univ, Shuang Ho Hosp, New Taipei, Taiwan
[4] Johns Hopkins Univ Hosp, Baltimore, MD 21287 USA
来源：
LABORATORY INVESTIGATION | 2019年 / 99卷
关键词：
D O I：
暂无
中图分类号：
R-3 [医学研究方法]; R3 [基础医学];
学科分类号：
1001 ;
摘要：
1000
引用
收藏
页数：2
相关论文
共 50 条
  • [1] Telomere Length in Precancerous Lesions of Ovarian Cancer Including p53 Signature and Incidental Serous Tubal Intraepithelial Carcinoma
    Asaka, Shiho
    Davis, Christine
    Lin, Shiou-Fu
    Wang, Tian-Li
    Heaphy, Christopher
    Shiho, le -Ming
    MODERN PATHOLOGY, 2019, 32
  • [2] Analysis of Telomere Lengths in p53 Signatures and Incidental Serous Tubal Intraepithelial Carcinomas Without Concurrent Ovarian Cancer
    Asaka, Shiho
    Davis, Christine
    Lin, Shiou-Fu
    Wang, Tian-Li
    Heaphy, Christopher M.
    Shih, Ie-Ming
    AMERICAN JOURNAL OF SURGICAL PATHOLOGY, 2019, 43 (08) : 1083 - 1091
  • [3] SEROUS TUBAL INTRAEPITHELIAL CARCINOMA (STIC): P53 SIGNATURE IN WOMEN WITHOUT HIGH RISK OF OVARIAN CANCER
    Barbosa, L.
    Napoleao, B.
    Ribeiro, M.
    Grande, R.
    Ferreira, P.
    Pedro, P.
    INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2019, 29 : A26 - A26
  • [4] Long Interspersed Element-1 Expression in Ovarian Cancers and Precancerous Lesions Including Serous Tubal Intraepithelial Carcinomas and p53 Signatures
    Asaka, Shiho
    Pisanic, Thomas
    Wang, Jeff
    Burns, Kathleen
    Wang, Tian-Li
    Shih, Ie-Ming
    LABORATORY INVESTIGATION, 2019, 99
  • [5] Long Interspersed Element-1 Expression in Ovarian Cancers and Precancerous Lesions Including Serous Tubal Intraepithelial Carcinomas and p53 Signatures
    Asaka, Shiho
    Pisanic, Thomas
    Wang, Jeff
    Burns, Kathleen
    Wang, Tian-Li
    Shih, le-Ming
    MODERN PATHOLOGY, 2019, 32
  • [6] The innovative role of p53 unbalance in precancerous lesions for serous ovarian carcinoma
    Asaturova, A.
    Kogan, E.
    Ezhova, L.
    Zharkov, N.
    Fayzullina, N.
    VIRCHOWS ARCHIV, 2015, 467 : S133 - S133
  • [7] THE EFFECT OF AGE AND OCP USE ON THE INCIDENCE OF PRECANCEROUS P53 LESIONS AND THE DEVELOPMENT OF HIGH GRADE SEROUS OVARIAN CARCINOMA
    Greening, Kendall
    Karnezis, Anthony
    Cochrane, Dawn
    Hanley, Gillian
    Huntsman, David
    CLINICAL CANCER RESEARCH, 2019, 25 (22) : 44 - 44
  • [8] p53 Signature and Serous Tubal In-situ Carcinoma in Cases of Primary Tubal and Peritoneal Carcinomas and Serous Borderline Tumors of the Ovary
    Leonhardt, Karoline
    Einenkel, Jens
    Sohr, Sindy
    Engeland, Kurt
    Horn, Lars-Christian
    INTERNATIONAL JOURNAL OF GYNECOLOGICAL PATHOLOGY, 2011, 30 (05) : 417 - 424
  • [9] Evidence for a latent precursor (p53 signature) that may precede serous endometrial intraepithelial carcinoma
    Jarboe, Elke A.
    Pizer, Ellen S.
    Miron, Alexander
    Monte, Nick
    Mutter, George L.
    Crum, Christopher P.
    MODERN PATHOLOGY, 2009, 22 (03) : 345 - 350
  • [10] Secretory cell outgrowths, p53 signatures, and serous tubal intraepithelial carcinoma in the fallopian tubes of patients with sporadic pelvic serous carcinoma
    Mittal, Neha
    Srinivasan, Radhika
    Gupta, Nalini
    Rajwanshi, Arvind
    Nijhawan, Raje
    Gautam, Upasana
    Sood, Swati
    Dhaliwal, Lakhbir
    INDIAN JOURNAL OF PATHOLOGY AND MICROBIOLOGY, 2016, 59 (04) : 481 - 488
12345